comparemela.com

Page 7 - Mini Mental State Examination News Today : Breaking News, Live Updates & Top Stories | Vimarsana

tDCS Shows Promise for Improving Cognitive Function in Patients With AD

Among patients with Alzheimer disease, twice daily tDCS may improve cognitive function, suggesting tDCS could be a therapeutic tool for AD.

Monoclonal Antibodies Provide Small Benefits in Alzheimer Disease

Monoclonal antibodies targeting amyloid provide small benefits on cognitive and functional scales, according to a study,

vimarsana © 2020. All Rights Reserved.